Japan Computed Tomography Market

Japan Computed Tomography Market Insights Forecasts to 2035

• The Japan Computed Tomography Market Size Was Estimated at USD 467 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 6.04% from 2025 to 2035
• The Japan Computed Tomography Market Size is Expected to Reach USD 890 Million by 2035

According to a research report published by decision advisor & Consulting, the Japan computed tomography Market size is anticipated to reach USD 890 Million by 2035, growing at a CAGR of 6.04% from 2025 to 2035. The Japan computed tomography market is driven by rising prevalence of chronic diseases, technological advancements in imaging, increasing geriatric population, growing healthcare expenditure, demand for early diagnosis, and adoption of AI-enabled CT scanners.

Market Overview

The Japan computed tomography market originally called computed axial tomography  is a sophisticated imaging procedure that utilizes a combination of computer technology and X-rays to generate cross-sectional of the body, including bones, blood vessels, and soft tissues. It involves the rotation of an X-ray tube around the patient, capturing multiple images from various angles, which are then processed by a computer to create detailed, 3D representations. These images offer a more comprehensive and precise view compared to conventional X-rays, allowing for improved diagnosis, treatment planning, and monitoring of diseases and conditions such as cancers, fractures, infections, and vascular disorders. CT is indispensable in emergency cases, like trauma assessments, where swift decision-making is crucial. The utility of CT scans extends to guiding surgical procedures and assessing the effectiveness of treatments, making it a pivotal tool in modern medical practice. Although highly informative, the usage of CT is moderated due to concerns regarding exposure to ionizing radiation, emphasizing the importance of justification and optimization in performing CT examinations.

According to the World Social Report 2023 report, published by the UN Department for Economic and Social Affairs, 29.1% of 125 million Japan were 65 years old or over. The country has often posed one of the lowest birth rates in the world and is grappling with the challenges of supporting its aging population. By the year 2040, it is estimated to rise to 34.8%. A parallel driver is the growing healthcare expenditure and investments in medical imaging, reinforcing the availability and accessibility of CT. Apart from this, the increasing demand for CT scans in minimally invasive and robotic surgical procedures to pre-operatively screen patients and determine the risk of mortality and morbidity is expected to drive the computed market in Japan.

Report Coverage

This research report categorizes the market for the Japan computed tomography market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan computed tomography market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan computed tomography market.

Driving Factors

The computed tomography markets in Japan are driven by the escalating prevalence of chronic conditions like cancer and cardiovascular diseases, which necessitates advanced imaging techniques for accurate diagnosis and treatment planning. Furthermore, the increasing incidents of accidents and traumas reinforce the indispensability of CT in emergency medical situations, thus contributing to market growth. For instance, in March 2024, canon medical systems corporation released an analysis of their novel photon counting technology. It is considered one of the major advancements in the field of medical imaging, which has enabled higher resolution in imaging, thus increasing diagnosis accuracy with reduced radiation dosage.

Restraining Factors

The computed tomography market in Japan is restrained by high equipment costs, strict regulations, limited reimbursement, aging hospital infrastructure, and slow adoption of advanced systems driven by financial constraints and workforce shortages.

Market Segmentation

The Japan computed tomography market share is categorized by type, application and end user. 

• The high slice segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.                                     

The Japan computed tomography market is segmented by type into low slice, medium slice, high slice, and others. Among these, the high slice segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is driven by it offers faster scanning, superior image quality, and advanced diagnostic capabilities. Growing demand for early disease detection, rising chronic illness prevalence, and increased hospital investment in premium imaging technologies further drive its strong forecasted growth.

• The oncology segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.  

The Japan computed tomography market is segmented by application into oncology, neurology, cardiovascular, musculoskeletal, and others. Among these, the oncology segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growth of the segment is due to rising cancer incidence, increasing reliance on CT for tumor detection, staging, and treatment planning, and widespread adoption of advanced imaging protocols. Expanding cancer screening programs and higher investment in precision medicine further support its strong projected growth.

• The hospitals segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.                                     

The Japan computed tomography market is segmented by end user hospitals, diagnostic centres, and others. Among these, the hospitals segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is driven by they manage high patient volumes, require advanced CT systems for emergency and complex cases, and have greater capital budgets. Their comprehensive diagnostic infrastructure and continuous modernization efforts further support strong, sustained growth during the forecast period.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan computed tomography market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies                                                                              

• Canon Medical Systems Corporation
• FUJIFILM Holdings Corporation
• GE HealthCare Technologies Inc
• Koninklijke Philips N.V
• Siemens Healthineers (Siemens AG)
• Others

Key Target Audience                           

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In January 2024, Canon Medical Systems Corporation introduced an AI-powered CT device that minimizes radiation exposure while retaining picture quality. This development expanded on their Aquilion series, which had been a key component of their CT offering in Japan.
• In March 2024, Fujifilm Healthcare Corporation updated its FCT Precision system with deep learning reconstruction technology, reducing radiation dose while retaining imaging quality. The system was created primarily to satisfy the needs of Japanese healthcare practitioners working with an aging population

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. decision advisor has segmented the Japan Computed Tomography Market based on the below-mentioned segments:

Japan Computed Tomography Market, By Type

• Low Slice
• Medium Slice
• High Slice
• Others

Japan Computed Tomography Market, By Application

• Oncology
• Neurology
• Cardiovascular
• Musculoskeletal
•  Others

Japan Computed Tomography Market, By End User

• Hospitals
• Diagnostic Centres
• Others

FAQ’s                                       

Q: What is the market size of the Japan Computed tomography market in 2024?

A: The Japan computed tomography market size was estimated at USD 467 million in 2024.

Q: What is the projected market value by 2035?

A: The market is expected to reach USD 890 million by 2035, growing at a CAGR of 6.04%.

Q: What factors are driving market growth in Japan?

A: Key drivers include rising chronic diseases, technological advancements, increased geriatric population, higher healthcare spending, and growing adoption of AI-enabled CT scanners.

Q: Which type segment held the largest share in 2024?

A: The high-slice CT segment held the largest share due to faster scanning, superior image quality, and advanced diagnostic capabilities.

Q: Which application segment dominated the market in 2024?

A: The oncology segment dominated, driven by rising cancer incidence and increased use of CT for tumour detection and treatment planning.

Q: Who are the major players in the Japan CT market?

A: Key players include Canon Medical Systems, FUJIFILM Holdings, GE healthcare, and Philips.